Title : Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.

Pub. Date : 2015 Jul

PMID : 25701378






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. Sirolimus Cbl proto-oncogene B Homo sapiens
2 Knockdown of Cbl-b significantly attenuated celecoxib-mediated inhibition of Akt phosphorylation and impaired the additive anticancer effect of celecoxib and rapamycin. Sirolimus Cbl proto-oncogene B Homo sapiens
3 Our results suggest that celecoxib-mediated upregulation of Cbl-b is responsible, at least in part, for the additive antitumor effect of celecoxib and rapamycin via inhibition of rapamycin-induced Akt activation. Sirolimus Cbl proto-oncogene B Homo sapiens
4 Our results suggest that celecoxib-mediated upregulation of Cbl-b is responsible, at least in part, for the additive antitumor effect of celecoxib and rapamycin via inhibition of rapamycin-induced Akt activation. Sirolimus Cbl proto-oncogene B Homo sapiens